About US
Contact us
-
MIT spinout Continuus Pharmaceuticals nets $69M to onshore production of critical medsMassachusetts Institute of Technology (MIT) spinout Continuus Pharmaceuticals is joining the push to bring drug manufacturing stateside, and it's tappedsome cutting-edge tech for the job. Armed with2021/1/29
-
Johnson & Johnson is 'comfortable' meeting coronavirus vaccine delivery promises, CFO saysAs the world awaits Johnson & Johnson’s phase 3 COVID-19 vaccine data, the companyis prepping for regulatory filings and a global rollout.Orders for hundreds of millions of doses are pending. But2021/1/27
-
Nostrum Labs adds another NDMA-tainted metformin lot to its growing recall2020's metformin recalls have bled into the new year. Just this week, Nostrum Laboratories, which already extended a product pull earlier this month, put another lot on the chopping block thanks to f2021/1/27
-
Novartis set to answer inclisiran's FDA rebuff by Q3. But what about an approval timeline?Novartis bought cholesterol drug inclisiran on the brink of a new drug filing as the centerpiece of its $9.7 billion acquisition of The Medicines Company. But, in the wake of an FDA rebuff amid the p2021/1/25
-
Moderna to test different booster shot against South Africa coronavirus variantModerna is weighing a second booster shot to battle back a new coronavirus variant, even as it affirms its current vaccine's activity against newly emerging mutants. While the current two-dose regime2021/1/25
-
The top 10 largest biopharma M&A deals in 2020Biopharma M&A activities suffered a slowdown in 2020. One could argue that 2019’s megadeals consumed some of last year’s quota, and COVID-19 definitely didn’t help. But AstraZeneca’s $39 billio2021/1/20
-
Samsung eyes manufacturing expansions into U.S. and beyond as work on Korean 'Super Plant' plows aheadSamsung Biologics was among a handful of manufacturers to enjoy a production boost during the COVID-19 pandemic. Now, as work on a "Super Plant" in its native South Korea progresses, the CDMO is draw2021/1/20
-
Woodcock to step up to interim FDA chief as she and Sharfstein are vetted for permanent job: reportsFDA veteran Janet Woodcock will take over as commissioner, at least temporarily, according to media reports, and former deputy FDA chief Joshua Sharfstein is at the top of the list for the permanent2021/1/18
-
Regeneron inks big new coronavirus antibody supply deal worth up to $2.6BPharma companies worldwide scrambled to respond to the COVID-19 pandemic early last year, but so faronly a few haveadvanced therapies and vaccines through to the market. Regeneron is one, and now the2021/1/18
-
What do Novartis deal, PD-1 competition in China mean for tislelizumab? Here's what BeiGene CEO has to sayBeiGene has had a few busy weeks. In its home base of China, the company won national reimbursement for three products. Outside of China, it just signed Novartis as a partner on immuno-oncology thera2021/1/15